Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,114.2
-12.0 (-0.38%)

 

  • STI Straits Times Index
    3,114.2
    -12.0 (-0.38%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    -3.4 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,719.6
    -128.9 (-0.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,938.1
    -39.2 (-1.32%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,191.9
    10.9 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 937.3M
  • Value: 879.2M
  • Rise: 114
  • Fall: 160
  • Unch: 558

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.002-
Rex Intl0.093+0.005
ThaiBev0.900+0.025
Genting Sing0.915-0.010
Spackman0.016-
YZJ Shipbldg SGD0.940-0.010
Y Ventures0.112+0.001
AEM1.280+0.020
KLW0.003-
Singapore-eDev0.045-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,089.5 -67.3
HSI 26,719.6 -128.9
HSCEI 10,540.0 -48.1
Jakarta 6,191.9 +10.9
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 18 Oct 2019 13:00
Last (SGD): 0.225 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.225
Buy Price 0.220 Sell Price 0.230
Buy Volume ('000) 50.0 Sell Volume ('000) 5.0
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.02578 Trailing EPS (SGD) e -0.02578 NAV (SGD) b 0.0445
PE a - Trailing PE f - Price / NAV b 5.0562
Dividend (SGD) d - Cash In Hand (SGD) g 0.0374 Issued & Paid-up Shares c 242,500,000
Dividend Yield (%) d - Price / Cash In Hand g 6.016 Treasury Shares h -
Beta - 75 Daysi -0.392 R-Squared - 75 Days(%)i 1.29 Market Cap (M) 54.562
Beta - 500 Daysi 0.897 R-Squared - 500 Days (%)i 2.76 Enterprise Value (M) 45.593
Piotroski F Score - Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP 0.263 Free Float (%) 99.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 54.562 - - 5.0562 -
Industry Medical & Biotechnology SGX 991.522 23.243 26.445 1.4277 1.820
Medical Specialties SGX 641.868 37.535 37.180 3.8907 0.887
Local Peer Top Glove SGX 3,687.248 30.252 30.254 4.6213 0.913
Local Peer Yunnan Energy SGX 43.794 - - 0.8923 -
Local Peer UG Healthcare SGX 31.894 12.722 12.722 0.7534 1.570
Local Peer Medtecs Intl SGX 17.032 13.656 13.244 0.2003 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 146,323.046 62.186 44.652 - 1.392
Global Peer MEDTRONIC PLC NYSE 145,061.360 31.324 32.819 2.8803 1.922
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 112,701.956 38.360 31.828 3.9229 0.260
Global Peer DANAHER CORP NYSE 99,003.958 37.347 40.469 3.2353 0.453
Global Peer STRYKER CORP NYSE 80,336.969 22.611 22.630 6.7267 0.899
Global Peer BECTON DICKINSON & CO NYSE 69,807.405 439.040 89.040 3.2476 1.160
Global Peer INTUITIVE SURGICAL INC NASDAQ 65,262.011 57.862 53.944 - -
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,587.556 32.069 38.387 5.6857 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,304.629 65.501 65.257 13.5144 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,923.822 27.662 28.397 5.7506 0.834
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), WATERS CORP (NYSE), DEXCOM INC (NASDAQ), COOPER COS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), HOLOGIC INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), STERIS PLC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), PERKINELMER INC (NYSE), COCHLEAR LTD (ASX), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HILL-ROM HOLDINGS INC (NYSE), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), HAEMONETICS CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), TANDEM DIABETES CARE INC (NASDAQ), LIVANOVA PLC (NASDAQ), NUVASIVE INC (NASDAQ), NEOGEN CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NASDAQ), TOPGLOV (Bursa), WRIGHT MEDICAL GROUP NV (NASDAQ), NEVRO CORP (NYSE), EBOS GROUP (ASX), QUIDEL CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), AVANOS MEDICAL INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), MICROPORT (HKEx), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), NATUS MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ATRICURE INC (NASDAQ), INOGEN INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AK MEDICAL (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), INMODE LTD (NASDAQ), CIRC (HKEx), CORINDUS VASCULAR ROBOTICS INC (NYSE American), LIFETECH SCI (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VERICEL CORP (NASDAQ), CERUS CORP (NASDAQ), SURMODICS INC (NASDAQ), HESKA CORP (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AXOGEN INC (NASDAQ), SUPERMX (Bursa), CUTERA INC (NASDAQ), YESTAR HEALTH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), AVEDRO INC (NASDAQ), SI BONE INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CORMEDIX INC (NYSE American), UTAH MEDICAL PRODUCTS (NASDAQ), ZYNEX INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), SIENTRA INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), GOLDEN MEDITECH (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), VIEWRAY INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PW MEDTECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), INOVIO PHARMACEUTICALS INC (NASDAQ), CRH MEDICAL CORP (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), SOLITON INC (NASDAQ), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), RTI SURGICAL HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), MODERN DENTAL (HKEx), NEURONETICS INC (NASDAQ), CONFORMIS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), FONAR CORP (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MY MEDICARE (HKEx), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SOMNOMED LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), YUNNAN ENERGY (HKEx), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), COMPUMEDICS (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NEPHROS INC (NASDAQ), SDI LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), ENDOLOGIX INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), MRI INTERVENTIONS INC (NYSE American), CYCLOPHARM LIMITED (ASX), ELECTROMED INC (NYSE American), KELFRED (HKEx), ELLEX MEDICAL LASERS LTD (ASX), ALPHA PRO TECH (NYSE American), ELECTROCORE INC (NASDAQ), IMPEDIMED LIMITED (ASX), ONCOCYTE CORP (NYSE American), VINCENT MED (HKEx), MOTUS GI HOLDINGS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), RESONANCE HEALTH LTD (ASX), DAXOR CORP (NYSE American), IMMUCELL CORP (NASDAQ), LIFE HEALTHCARE (HKEx), MICRO-X LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), CELSION CORPORATION (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), ZOSANO PHARMA CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), NUVECTRA CORPORATION (NASDAQ), BIOMERICA INC (NASDAQ), RESPIRI LTD (ASX), NEOVASC INC (NASDAQ), ADMEDUS LTD (ASX), IRIDEX CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LBT INNOVATIONS LTD (ASX), OBJ LIMITED (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ADVENTA (Bursa), BIOLASE INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TITAN MEDICAL INC (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), ATOSSA GENETICS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), CARDIEX LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), OPTISCAN IMAGING (ASX), LIANLUO SMART LIMITED (NASDAQ), COMBEST HOLD (HKEx), USCOM LTD (ASX), DIMERIX LTD (ASX), AVINGER INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), LKL (Bursa), OBALON THERAPEUTICS INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), ANALYTICA (ASX), INSPIREMD INC (NYSE American), NEUROTROPE INC (NASDAQ), DIGIRAD CORP (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), DYNATRONICS CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MICRON SOLUTIONS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ADHERIUM LIMITED (ASX), STHAI (SET), CH DEMETER FIN (HKEx), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), METALICITY LIMITED (ASX), NEUROMETRIX INC (NASDAQ), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-2.17 %
10 Days --0.030
-11.76 %
20 Days --0.035
-13.46 %
Medium Term Return 3 Months --0.055
-19.64 %
6 Months --0.070
-23.73 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.180 - 0.330 Change From 1 Year Low +0.045 % Change From 1 Year Low (%) +25.00
Change From 1 Year High -0.105 % Change From 1 Year High (%) -31.82
2 Years Range 0.180 - 0.330 Change From 2 Years Low +0.045 % Change From 2 Years Low (%) +25.00
Change From 2 Years High -0.105 % Change From 2 Years High (%) -31.82
5 Years Range 0.180 - 0.330 Change From 5 Years Low +0.045 % Change From 5 Years Low (%) +25.00
Change From 5 Years High -0.105 % Change From 5 Years High (%) -31.82
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) -19.64 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2019 0.225 0.225 0.225 0.225 - -
17 Oct 2019 0.225 0.225 0.220 0.225 115,100 0.2233
16 Oct 2019 0.230 0.230 0.230 0.230 - -
15 Oct 2019 0.230 0.230 0.230 0.230 - -
14 Oct 2019 0.230 0.230 0.230 0.230 - -
11 Oct 2019 0.225 0.230 0.225 0.230 223,200 0.2252
10 Oct 2019 0.225 0.230 0.225 0.230 60,000 0.2258
09 Oct 2019 0.230 0.230 0.225 0.230 48,300 0.2300
08 Oct 2019 0.240 0.260 0.225 0.240 147,600 0.2329
07 Oct 2019 0.255 0.255 0.255 0.255 - -
04 Oct 2019 0.255 0.255 0.255 0.255 - -
03 Oct 2019 0.255 0.255 0.255 0.255 - -
02 Oct 2019 0.240 0.255 0.225 0.255 63,900 0.2304
01 Oct 2019 0.240 0.240 0.220 0.230 10,800 0.2333
30 Sep 2019 0.250 0.250 0.250 0.250 - -
27 Sep 2019 0.250 0.250 0.230 0.250 10,200 0.2403
26 Sep 2019 0.250 0.260 0.230 0.240 29,300 0.2449
25 Sep 2019 0.260 0.260 0.260 0.260 - -
24 Sep 2019 0.260 0.260 0.260 0.260 - -
23 Sep 2019 0.260 0.260 0.260 0.260 - -
20 Sep 2019 0.260 0.260 0.260 0.260 - -
19 Sep 2019 0.250 0.275 0.250 0.260 17,400 0.2559
Summary
Current 2 Weeks
(07 Oct 2019 to 18 Oct 2019)
0.255 0.260 0.220 0.225 594,200 -
Previous 2 Weeks
(23 Sep 2019 to 04 Oct 2019)
0.260 0.260 0.220 0.255 114,200 -
4 Weeks from
(26 Aug 2019 to 20 Sep 2019)
0.220 0.260 0.215 0.260 665,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.